-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENERON PHARMACEUTICALS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $997 FROM $835

Reuters·11/02/2026 11:36:34

Please log in to view news